NOT-DE-24-005: Notice of NIDCR Participation in RFA-NS-23-007, "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)"

Notice of NIDCR Participation in RFA-NS-23-007, "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)"

Notice Number:

NOT-DE-24-005

Key Dates

Release Date:

October 16, 2023

Related Announcements

September 15, 2022 - HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed). See NOFO RFA-NS-23-007.

Issued by

National Institute of Dental and Craniofacial Research (NIDCR)

Purpose

This Notice announces the participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-NS-23-007, "HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)," effective immediately.

The following text has been added to reflect NIDCR’s participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Dental and Craniofacial Research (NIDCR)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.121

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Melissa Ghim, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-496-7853
Email: melissa.ghim@nih.gov

Financial/Grants Management Contact(s)

Gabriel Hidalgo, MBA
Dental and Craniofacial Research (NIDCR)
Telephone: 301-827-4630
Email: hidalgoge@mail.nih.gov

Inquiries

Please direct all inquiries to:

Melissa M. Ghim, PhD
National Institute of Dental and Craniofacial Research
Telephone: 301-496-7853
Email: melissa.ghim@nih.gov